Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD Repeat Domain 12 pseudogene 2 (WDR12P2) is a genomic sequence similar to the protein-coding WDR12 gene, but it is classified as a pseudogene, meaning it does not produce a functional protein. There is no evidence that WDR12P2 serves as a druggable target or participates in biological pathways relevant to disease or pharmacology. Research on relatives of WDR12P2—such as the canonical WDR12 gene—implicates those in ribosome biogenesis, cell proliferation, and certain diseases, specifically cardiovascular disease and cancer, but these characteristics do not extend to the pseudogene itself[1][2][3][4][5][6].
None for pseudogene. No drug mechanisms have been established for targeting WDR12P2 or WDR12.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD Repeat Domain 12 pseudogene 2 (WDR12P2).